Clinical · Comorbidities
HRT After Endometrial Cancer
Case-by-case with oncology; often contraindicated but not always.
Case-by-case with oncology; often contraindicated but not always. Kindr Health clinicians coordinate care with your existing specialists.
Decision framework
Individual risk-benefit, route of administration matters (transdermal bypasses hepatic first-pass), and current guidelines from NAMS, ACOG, and disease-specific societies.
What we do differently
We don't reflexively deny HRT for common comorbidities. Guidelines have evolved — many older 'contraindications' are now nuanced case-by-case decisions.
Frequently asked questions
Will my specialist agree?
We coordinate directly with your care team when helpful; most modern specialists follow current guidelines.
Is transdermal really safer?
For most vascular and metabolic conditions, yes — it bypasses liver first-pass.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.